Yüklüyor......
Study Sets Response Benchmarks for FLT3‐Inhibitor Sequencing in FLT3‐Mutated AML
A new study of sequential exposure to FLT3 inhibitors demonstrates the benefits of these therapies across multiple lines and treatment settings for patients with FLT3‐mutated acute myeloid leukemia.
Kaydedildi:
| Yayımlandı: | Oncologist |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
John Wiley & Sons, Inc.
2020
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7869113/ https://ncbi.nlm.nih.gov/pubmed/33368881 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/onco.13648 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|